Name: Intuitive Surgical Inc. (NASDAQ:ISRG) | Liabilities and Stockholders’ Equity (Quarterly)
Creator: Stock Analysis on Net

Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Download chart

Intuitive Surgical Inc., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in thousands

	Sep 30, 2026	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Accounts payable	279,500)	277,200)	332,900)	255,100)	291,200)	266,800)	276,200)	193,400)	218,700)	194,400)	194,400)	188,700)	196,200)	199,700)	164,100)	147,000)	164,200)	149,700)	128,100)	121,200)	120,000)	117,900)	103,100)
Accrued compensation and employee benefits	505,900)	425,700)	370,700)	648,400)	455,500)	420,800)	309,700)	535,600)	377,500)	321,300)	238,400)	436,400)	374,800)	346,600)	260,900)	401,600)	308,200)	278,600)	219,800)	350,100)	265,300)	254,000)	194,800)
Deferred revenue	541,200)	549,400)	559,500)	506,700)	491,100)	499,900)	496,300)	468,800)	426,000)	433,900)	437,500)	446,100)	394,800)	405,200)	417,800)	397,300)	358,900)	376,300)	386,000)	377,200)	348,500)	360,000)	358,100)
Other accrued liabilities	1,206,400)	670,600)	647,900)	596,000)	565,400)	505,100)	455,900)	547,500)	654,600)	537,900)	504,800)	587,500)	710,600)	586,900)	464,600)	476,200)	402,100)	370,400)	378,300)	301,300)	293,500)	272,700)	248,600)
Current liabilities	2,533,000)	1,922,900)	1,911,000)	2,006,200)	1,803,200)	1,692,600)	1,538,100)	1,745,300)	1,676,800)	1,487,500)	1,375,100)	1,658,700)	1,676,400)	1,538,400)	1,307,400)	1,422,100)	1,233,400)	1,175,000)	1,112,200)	1,149,800)	1,027,300)	1,004,600)	904,600)
Other long-term liabilities	698,300)	656,000)	602,800)	510,800)	506,500)	517,500)	474,600)	468,300)	389,100)	365,900)	406,500)	385,500)	412,800)	405,200)	451,600)	439,300)	453,400)	447,800)	409,300)	453,700)	447,800)	412,900)	445,600)
Long-term liabilities	698,300)	656,000)	602,800)	510,800)	506,500)	517,500)	474,600)	468,300)	389,100)	365,900)	406,500)	385,500)	412,800)	405,200)	451,600)	439,300)	453,400)	447,800)	409,300)	453,700)	447,800)	412,900)	445,600)
Total liabilities	3,231,300)	2,578,900)	2,513,800)	2,517,000)	2,309,700)	2,210,100)	2,012,700)	2,213,600)	2,065,900)	1,853,400)	1,781,600)	2,044,200)	2,089,200)	1,943,600)	1,759,000)	1,861,400)	1,686,800)	1,622,800)	1,521,500)	1,603,500)	1,475,100)	1,417,500)	1,350,200)
Preferred stock, $0.001 par value, issuable in series; zero shares issued and outstanding	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Common stock, $0.001 par value	300)	400)	400)	400)	400)	400)	400)	400)	400)	400)	400)	400)	400)	400)	400)	400)	400)	400)	400)	400)	400)	100)	100)
Additional paid-in capital	11,521,100)	11,325,000)	11,059,900)	10,768,500)	10,478,800)	10,236,800)	9,993,700)	9,681,300)	9,440,200)	9,149,700)	8,903,000)	8,576,400)	8,385,900)	8,150,800)	7,928,400)	7,703,900)	7,684,800)	7,484,000)	7,354,600)	7,164,000)	7,015,100)	6,804,400)	6,627,300)
Retained earnings	4,525,100)	6,837,200)	6,397,700)	7,011,800)	6,424,000)	7,605,500)	7,139,400)	6,803,300)	6,129,800)	5,581,700)	5,067,900)	4,743,000)	4,209,200)	3,807,700)	3,397,400)	3,500,100)	4,017,800)	4,682,800)	4,858,000)	4,760,900)	4,390,100)	4,022,700)	3,514,700)
Accumulated other comprehensive income (loss)	(60,300)	5,800)	16,500)	43,300)	26,500)	3,000)	(27,100)	(51,300)	12,900)	(23,500)	(8,700)	(12,200)	(56,500)	(79,800)	(108,500)	(162,500)	(187,600)	(144,200)	(110,700)	(24,200)	5,300)	10,300)	11,400)
Total Intuitive Surgical, Inc. stockholders’ equity	15,986,200)	18,168,400)	17,474,500)	17,824,000)	16,929,700)	17,845,700)	17,106,400)	16,433,700)	15,583,300)	14,708,300)	13,962,600)	13,307,600)	12,539,000)	11,879,100)	11,217,700)	11,041,900)	11,515,400)	12,023,000)	12,102,300)	11,901,100)	11,410,900)	10,837,500)	10,153,500)
Noncontrolling interest in joint venture	131,600)	129,300)	122,700)	117,700)	112,400)	107,400)	101,300)	95,900)	94,200)	88,200)	83,800)	89,700)	84,500)	80,600)	76,500)	70,700)	58,600)	59,400)	54,600)	50,400)	48,600)	42,000)	36,700)
Total stockholders’ equity	16,117,800)	18,297,700)	17,597,200)	17,941,700)	17,042,100)	17,953,100)	17,207,700)	16,529,600)	15,677,500)	14,796,500)	14,046,400)	13,397,300)	12,623,500)	11,959,700)	11,294,200)	11,112,600)	11,574,000)	12,082,400)	12,156,900)	11,951,500)	11,459,500)	10,879,500)	10,190,200)
Total liabilities and stockholders’ equity	19,349,100)	20,876,600)	20,111,000)	20,458,700)	19,351,800)	20,163,200)	19,220,400)	18,743,200)	17,743,400)	16,649,900)	15,828,000)	15,441,500)	14,712,700)	13,903,300)	13,053,200)	12,974,000)	13,260,800)	13,705,200)	13,678,400)	13,555,000)	12,934,600)	12,297,000)	11,540,400)

The balance sheet exhibits a general expansion in total liabilities and stockholders' equity over the analyzed period, moving from 11.54 billion USD in March 2021 to 19.35 billion USD by September 2026. While the overall scale of the balance sheet grew, the composition of funding and obligations shifted, characterized by a significant increase in current liabilities and a volatile trajectory in retained earnings toward the end of the period.

Liability Trends and Composition: Total liabilities experienced a steady upward trajectory, increasing from 1.35 billion USD in March 2021 to 3.23 billion USD in September 2026. This growth is primarily driven by current liabilities, which rose from 904.6 million USD to 2.53 billion USD. A notable surge is observed in other accrued liabilities, which climbed from 248.6 million USD at the start of the period to a peak of 1.21 billion USD in the final quarter. Accounts payable and accrued compensation also showed consistent growth, reflecting increased operational scale and workforce-related obligations. Long-term liabilities remained relatively stable for several years before beginning a gradual ascent from 445.6 million USD in March 2021 to 698.3 million USD by September 2026.
Stockholders' Equity and Capital Structure: Total stockholders' equity grew from 10.19 billion USD in March 2021 to a peak of 18.30 billion USD in June 2026, before declining to 16.12 billion USD in September 2026. A primary driver of this equity growth was the additional paid-in capital, which rose consistently from 6.63 billion USD to 11.52 billion USD. In contrast, retained earnings exhibited significant volatility; after growing from 3.51 billion USD to a peak of 7.61 billion USD in June 2025, the balance fell sharply to 4.53 billion USD by September 2026, suggesting substantial capital distributions or offsetting losses in the final year.
Deferred Revenue and Operational Obligations: Deferred revenue showed a gradual and stable increase from 358.1 million USD in March 2021 to 541.2 million USD in September 2026. This steady climb indicates a consistent growth in advance payments for services or products, providing a reliable source of short-term funding for operations. The growth in deferred revenue is modest compared to the more aggressive increases seen in other current liability accounts, suggesting that the overall rise in liabilities is driven more by accrued expenses than by customer deposits.
Financial Leverage and Stability: The relationship between liabilities and equity indicates a strong equity-funded position for the majority of the period. However, the final quarter of 2026 shows a shift, with a simultaneous spike in total liabilities and a contraction in total stockholders' equity. This convergence suggests a transition toward higher leverage in the most recent reporting period, as the total liabilities increased by approximately 650 million USD while equity decreased by roughly 2.18 billion USD between June and September 2026.

AI Ask an analyst for more

My previous chats

Add tokens

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?

Intuitive Surgical Inc. (NASDAQ:ISRG)

Balance Sheet: Liabilities and Stockholders’ EquityQuarterly Data

Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data